Table 3.

Experimental design and sequence of the assessments.

#	Encounters	General administration	Assessment tools
1st	Referral	Randomization (assignment to the placebo or to the oxytocin group	Beck’s (2001) criteria scale
2nd	Pre-treatment assessment meeting	No substance administration	EPDS, HDRS, ANPS scales
3rd	First psychotherapic encounter	Beginning of the daily administration of substance (either Oxytocin or Placebo)	SWAP scale by the therapist after the first session
4th– 13th	Weekly sessions of psychotherapy (globally 12 sessions)	Continuation of daily administration of substance (either oxytocin or placebo)	Weekly follow-up supervision sessions by the team of psychotherapists
14th	On the 12th Psychotherapic encounter	Continuation of daily administration of substance (either oxytocin or placebo)	SWAP scale by the therapist after the last session
15th	Post-treatment assessment meeting	Discontinuation of daily administration of substance	EPDS, HDRS, ANPS scales